Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
Saved in:
| Main Authors: | Maki Komiyama, Yuka Ozaki, Hiromichi Wada, Hajime Yamakage, Noriko Satoh-Asahara, Akihiro Yasoda, Yoichi Sunagawa, Tatsuya Morimoto, Yuko Takahashi, Koji Hasegawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2023-04-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2023.18.PO13 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus
by: Masafumi Funamoto, et al.
Published: (2019-01-01) -
Yokukansan (Kampo medicinal formula) prevents the development of morphine tolerance by inhibiting the secretion of orexin A
by: Ayami Katayama, et al.
Published: (2018-06-01) -
Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy
by: Shiori Kawai, et al.
Published: (2023-12-01) -
Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
by: Takeyoshi K, et al.
Published: (2016-03-01) -
Comparison of the utility of SARC-F, SARC-CalF, and calf circumference as screening tools for sarcopenia in patients with osteoporosis.
by: Yuki Ishihara, et al.
Published: (2024-01-01)